These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
419 related items for PubMed ID: 12131541
1. Left ventricular remodeling impairs coronary flow reserve in hypertensive patients. Schäfer S, Kelm M, Mingers S, Strauer BE. J Hypertens; 2002 Jul; 20(7):1431-7. PubMed ID: 12131541 [Abstract] [Full Text] [Related]
2. Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension. Nishikimi T, Yoshihara F, Morimoto A, Ishikawa K, Ishimitsu T, Saito Y, Kangawa K, Matsuo H, Omae T, Matsuoka H. Hypertension; 1996 Jul; 28(1):22-30. PubMed ID: 8675258 [Abstract] [Full Text] [Related]
3. [Assessment of coronary reserve in patients with hypertensive disease and without hypertrophy left ventricular]. Iskenderov BG, Shibaeva TM, Minkin AA, Bogdanova SR. Kardiologiia; 2005 Jul; 45(3):10-3. PubMed ID: 15821701 [Abstract] [Full Text] [Related]
4. Mechanisms of coronary flow reserve impairment in human hypertension. An integrated approach by transthoracic and transesophageal echocardiography. Kozàkovà M, Palombo C, Pratali L, Pittella G, Galetta F, L'Abbate A. Hypertension; 1997 Feb; 29(2):551-9. PubMed ID: 9040437 [Abstract] [Full Text] [Related]
5. Relationship between vascular damage and left ventricular concentric geometry in patients undergoing coronary angiography: a multicenter prospective study. Salvetti M, Paini A, Facchetti R, Moreo A, Carerj S, Maloberti A, Gaibazzi N, Faggiano P, Mureddu G, Rigo F, Giannattasio C, Muiesan ML, APRES Study Group. J Hypertens; 2019 Jun; 37(6):1183-1190. PubMed ID: 30882598 [Abstract] [Full Text] [Related]
6. Relation of arterial structure and function to left ventricular geometric patterns in hypertensive adults. Roman MJ, Pickering TG, Schwartz JE, Pini R, Devereux RB. J Am Coll Cardiol; 1996 Sep; 28(3):751-6. PubMed ID: 8772767 [Abstract] [Full Text] [Related]
7. Left ventricular function and hemodynamic features of inappropriate left ventricular hypertrophy in patients with systemic hypertension: the LIFE study. Palmieri V, Wachtell K, Gerdts E, Bella JN, Papademetriou V, Tuxen C, Nieminen MS, Dahlöf B, de Simone G, Devereux RB. Am Heart J; 2001 May; 141(5):784-91. PubMed ID: 11320367 [Abstract] [Full Text] [Related]
12. Effects of spironolactone during an angiotensin II receptor blocker treatment on the left ventricular mass reduction in hypertensive patients with concentric left ventricular hypertrophy. Taniguchi I, Kawai M, Date T, Yoshida S, Seki S, Taniguchi M, Shimizu M, Mochizuki S. Circ J; 2006 Aug; 70(8):995-1000. PubMed ID: 16864931 [Abstract] [Full Text] [Related]
13. Left ventricular filling patterns in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study). Losartan Intervention For Endpoint. Wachtell K, Smith G, Gerdts E, Dahlöf B, Nieminen MS, Papademetriou V, Bella JN, Ibsen H, Rokkedal J, Devereux RB. Am J Cardiol; 2000 Feb 15; 85(4):466-72. PubMed ID: 10728952 [Abstract] [Full Text] [Related]
14. Systolic left ventricular function according to left ventricular concentricity and dilatation in hypertensive patients: the Losartan Intervention For Endpoint reduction in hypertension study. Bang CN, Gerdts E, Aurigemma GP, Boman K, Dahlöf B, Roman MJ, Køber L, Wachtell K, Devereux RB. J Hypertens; 2013 Oct 15; 31(10):2060-8. PubMed ID: 23838656 [Abstract] [Full Text] [Related]
16. Four-group classification of left ventricular hypertrophy based on ventricular concentricity and dilatation identifies a low-risk subset of eccentric hypertrophy in hypertensive patients. Bang CN, Gerdts E, Aurigemma GP, Boman K, de Simone G, Dahlöf B, Køber L, Wachtell K, Devereux RB. Circ Cardiovasc Imaging; 2014 May 15; 7(3):422-9. PubMed ID: 24723582 [Abstract] [Full Text] [Related]
17. Echocardiographic Left Ventricular Reverse Remodeling After 18 Months of Antihypertensive Treatment in Stage I Hypertension. Results From the Prever-Treatment Study. Bertoluci C, Foppa M, Santos ABS, Branchi TV, Fuchs SC, Fuchs FD. Am J Hypertens; 2018 Feb 09; 31(3):321-328. PubMed ID: 29036504 [Abstract] [Full Text] [Related]
18. Endogenous ouabain and hemodynamic and left ventricular geometric patterns in essential hypertension. Pierdomenico SD, Bucci A, Manunta P, Rivera R, Ferrandi M, Hamlyn JM, Lapenna D, Cuccurullo F, Mezzetti A. Am J Hypertens; 2001 Jan 09; 14(1):44-50. PubMed ID: 11206678 [Abstract] [Full Text] [Related]